Amelia Tomlinson

Amelia Tomlinson, PhD has a diverse and extensive work experience in the medical and scientific field. Amelia currently holds the position of Global Pre-Launch Strategy Lead at Galderma. Prior to this, they worked as the Director of Global Medical Affairs at Arena Pharmaceuticals, Inc. Amelia also served as the Director of Clinical Science and Head of Medical Communications at resTORbio, where they led the development and execution of medical communications and publications strategy.

Amelia has also held positions at Seres Therapeutics, where they worked as a Director of Clinical Science and Senior Clinical Scientist, playing a key role in the development of a first-in-class microbiome therapeutic. At OpenBiome, they worked as a Clinical Research Manager and Clinical Scientist, managing multi-site clinical trials and writing regulatory documents.

Earlier in their career, Amelia worked at EBSCO Information Services as the Associate Managing Editor, overseeing content strategy, and as a Senior Medical Writer. Amelia also worked at Indiana University Bloomington as a Researcher, Visiting Lecturer, and Graduate Research Assistant, conducting various research projects and teaching courses in molecular genetics and microbiology. Prior to that, they worked as a Research Specialist at Emory University School of Medicine, contributing to research on bacterial effector proteins.

Overall, Amelia Tomlinson, PhD has demonstrated expertise in medical communications, clinical science, research, and teaching throughout their career.

Amelia Tomlinson, PhD obtained their Bachelor of Arts (BA) degree in Biology from Agnes Scott College. Amelia then pursued their doctoral studies in Microbiology and Plant Science at Indiana University Bloomington, earning their Ph.D.